MetLife Investment Management’s CARGO Therapeutics CRGX Stock Holding History

MetLife Investment Management’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,430	Closed	-$96.5K	–	2859
2025 Q2	$96.5K	Buy	23,430 +6,358	+37%	+$27.2K	﹤0.01%	2558
2025 Q1	$69.5K	Sell	17,072 -5,967	-26%	-$40K	﹤0.01%	2647
2024 Q4	$332K	Buy	23,039 +3,206	+16%	+$58.2K	﹤0.01%	2014
2024 Q3	$366K	Buy	19,833 +7,380	+59%	+$132K	﹤0.01%	1959
2024 Q2	$204K	Buy	12,453 +1,162	+10%	+$22.1K	﹤0.01%	2229
2024 Q1	$252K	Buy	+11,291	New	+$269K	﹤0.01%	2066

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MetLife Investment Management's CRGX Position: Q3 2025 in Review

MetLife Investment Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 23,430 shares — an estimated $96.5K sold.

MetLife Investment Management first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $366K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

MetLife Investment Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
MetLife Investment Management sold 23,430 CARGO Therapeutics shares in Q3 2025, an estimated $96.5K.
MetLife Investment Management first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
MetLife Investment Management's CARGO Therapeutics position peaked at $366K in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.